This method quantifies tamoxifen and 13 metabolites in various human and animal matrixes. The method chromatographically separates clinically relevant isomers of the active tamoxifen metabolites endoxifen and 4-hydroxy-tamoxifen.
Sample types: Human serum, plasma, bonemarrow plasma, breast milk and tissue. Mouse plasma and tissue.
Volumes required: 25 mg for tissue and 20 uL for liquid matrixes
Analytes measured: Tamoxifen, ND-tamoxifen, 4OH-tamoxifen (Z, E and Z-4' isomers), 3OH-tamoxifen, endoxifen (Z, E and Z,E-4' isomers), Tamoxifen-N-oxide, NNDD-tamoxifen, Z-α-tamoxifen, cis-β-tamoxifen.
Sample processing: Protein precipitation (+homogenization for tissue samples)
LC-MS/MS instrument: Waters Acquity UPLC Classic, Waters Xevo TQ-S
The validation of the method in various matrixes have been published separately:
Tamoxifen in human serum
Tamoxien in bone marrow plasma
Tamoxifen in breast milk
Tamoxifen in human breast tissue